RLAY

Relay Therapeutics
RLAY

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$710.34M
EV
$87.74M
Shares Outstanding
172.41M
Beta
1.60

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$13.60
P/E 2025E
-
P/Revenue 2025E
54.75x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Relay Therapeutics, Inc.

gainify
RLAY

Relay Therapeutics, Inc.

RLAY

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The c...

Sector

Healthcare

Industry

Biotechnology

CEO

Patel, Sanjiv

Employees

197

IPO Date

2020-07-16

Headquarters

399 Binney Street, 2nd Floor, Cambridge, Massachusetts, 02139, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.